Investigative Ophthalmology & Visual Science, Vol 36, 1934-1942, Copyright © 1995 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Clinical expression correlates with location of rhodopsin mutation in dominant retinitis pigmentosa

MA Sandberg, C Weigel-DiFranco, TP Dryja and EL Berson
Berman-Gund Laboratory, Massachusetts Eye and Ear Infirmary, Boston 02114, USA.

PURPOSE. To determine whether severity of retinitis pigmentosa caused by dominant rhodopsin mutations depends on the location altered by the mutation. METHODS. Data from 128 patients (age range, 7 to 73 years), each with 1 to 27 rhodopsin mutations, were analyzed. To approximate normal distributions, visual acuities were converted to ranks and then to the normal form, kinetic visual fields to a V4e test light were converted to equivalent diameters, and dark-adapted sensitivities to an 11 degrees diameter stimulus and electroretinogram (ERG) amplitudes to full-field 0.5-Hz and 30-Hz flashes were converted to common logarithms. Each of these measures was then regressed on age, refractive error (for the ERG), and domain (intradiscal, transmembrane, or cytoplasmic) or codon number of the opsin molecule altered by the mutation. RESULTS. All five measures of function varied significantly with the domain (P < or = 0.0007) or codon number (P < 0.0001) altered by a mutation; visual acuity, visual field diameter, dark-adapted sensitivity, and ERG amplitudes were highest for mutations altering the intradiscal domain or low-numbered codons and lowest for mutations altering the cytoplasmic domain or high-numbered codons. CONCLUSIONS. These data indicate that severity of disease correlates with the location of the amino acid residue altered by a rhodopsin mutation in dominant retinitis pigmentosa.

This article has been cited by other articles:

				J. Neidhardt, D. Barthelmes, F. Farahmand, J. C. Fleischhauer, and W. Berger Different amino Acid substitutions at the same position in rhodopsin lead to distinct phenotypes. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1630 - 1635. [Abstract] [Full Text] [PDF]

				Y. Wada, M. A. Sandberg, T. L. McGee, M. A. Stillberger, E. L. Berson, and T. P. Dryja Screen of the IMPDH1 Gene among Patients with Dominant Retinitis Pigmentosa and Clinical Features Associated with the Most Common Mutation, Asp226Asn Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1735 - 1741. [Abstract] [Full Text] [PDF]

				K T Oh, D M Oh, R G Weleber, E M Stone, A Parikh, J White, K A DeBoer-Shields, L Streb, and C Vallar Genotype-phenotype correlation in a family with Arg135Leu rhodopsin retinitis pigmentosa Br. J. Ophthalmol., December 1, 2004; 88(12): 1533 - 1537. [Abstract] [Full Text] [PDF]

				M. Martinez-Gimeno, M. J. Gamundi, I. Hernan, M. Maseras, E. Milla, C. Ayuso, B. Garcia-Sandoval, M. Beneyto, C. Vilela, M. Baiget, et al. Mutations in the Pre-mRNA Splicing-Factor Genes PRPF3, PRPF8, and PRPF31 in Spanish Families with Autosomal Dominant Retinitis Pigmentosa Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2171 - 2177. [Abstract] [Full Text] [PDF]

				D. K. Vaughan, S. F. Coulibaly, R. M. Darrow, and D. T. Organisciak A Morphometric Study of Light-Induced Damage in Transgenic Rat Models of Retinitis Pigmentosa Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 848 - 855. [Abstract] [Full Text] [PDF]

				E. L. Berson, B. Rosner, C. Weigel-DiFranco, T. P. Dryja, and M. A. Sandberg Disease Progression in Patients with Dominant Retinitis Pigmentosa and Rhodopsin Mutations Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3027 - 3036. [Abstract] [Full Text] [PDF]

				C. Rivolta, D. Sharon, M. M. DeAngelis, and T. P. Dryja Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns Hum. Mol. Genet., May 15, 2002; 11(10): 1219 - 1227. [Abstract] [Full Text] [PDF]

				V. Traverso, R. A. Bush, P. A. Sieving, and D. Deretic Retinal cAMP Levels during the Progression of Retinal Degeneration in Rhodopsin P23H and S334ter Transgenic Rats Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1655 - 1661. [Abstract] [Full Text] [PDF]

				M. M. DeAngelis, J. L. Grimsby, M. A. Sandberg, E. L. Berson, and T. P. Dryja Novel Mutations in the NRL Gene and Associated Clinical Findings in Patients With Dominant Retinitis Pigmentosa Arch Ophthalmol, March 1, 2002; 120(3): 369 - 375. [Abstract] [Full Text] [PDF]

				E. L. Berson, J. L. Grimsby, S. M. Adams, T. L. McGee, E. Sweklo, E. A. Pierce, M. A. Sandberg, and T. P. Dryja Clinical Features and Mutations in Patients with Dominant Retinitis Pigmentosa-1 (RP1) Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2217 - 2224. [Abstract] [Full Text] [PDF]

				W. M. Chan, K. Y. Yeung, C. P. Pang, L. Baum, T. C. Lau, A. K. H. Kwok, and D. S. C. Lam Rhodopsin mutations in Chinese patients with retinitis pigmentosa Br. J. Ophthalmol., September 1, 2001; 85(9): 1046 - 1048. [Abstract] [Full Text] [PDF]

				B. M. Tam, O. L. Moritz, L. B. Hurd, and D. S. Papermaster Identification of an Outer Segment Targeting Signal in the COOH Terminus of Rhodopsin Using Transgenic Xenopus laevis J. Cell Biol., December 18, 2000; 151(7): 1369 - 1380. [Abstract] [Full Text] [PDF]

				K. T. Oh, R. G. Weleber, A. Lotery, D. M. Oh, A. M. Billingslea, and E. M. Stone Description of a New Mutation in Rhodopsin, Pro23Ala, and Comparison With Electroretinographic and Clinical Characteristics of the Pro23His Mutation Arch Ophthalmol, September 1, 2000; 118(9): 1269 - 1276. [Abstract] [Full Text] [PDF]

				D. Deretic, S. Schmerl, P. A. Hargrave, A. Arendt, and J. H. McDowell Regulation of sorting and post-Golgi trafficking of rhodopsin by its C-terminal sequence QVS(A)PA PNAS, September 1, 1998; 95(18): 10620 - 10625. [Abstract] [Full Text] [PDF]

				A. V. Cideciyan, D. C. Hood, Y. Huang, E. Banin, Z.-Y. Li, E. M. Stone, A. H. Milam, and S. G. Jacobson Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man PNAS, June 9, 1998; 95(12): 7103 - 7108. [Abstract] [Full Text] [PDF]